Hold a single-use plastic spoon in your hand — the kind that comes with takeout food and gets thrown away after one meal. It weighs about seven grams. According to a peer-reviewed paper published in Nature Medicine on 3 February 2025, that approximate mass of plastic is roughly what the average adult human brain now contains, distributed throughout the frontal cortex in the form of microscopic shards, fragments, and nanoparticles of polyethylene and a handful of other common consumer polymers. The researchers who produced the finding were so surprised by their own data that, in the words of one of the study’s senior authors, Andrew West of Duke University, they “didn’t believe it” until multiple complementary measurement techniques on multiple samples kept producing the same result. The result was that human brains, in 2024, contained approximately 50 percent more microplastic by mass than human brains preserved from autopsies in 2016 — and that the absolute concentrations in brain tissue were roughly seven to thirty times higher than in liver or kidney samples from the same bodies.
According to the original paper by Alexander J. Nihart and colleagues at the University of New Mexico Health Sciences Center, published in Nature Medicine, the research team analysed 52 human brain samples from frontal-cortex tissue collected at autopsy in two periods: early 2016 and early 2024. They also examined liver and kidney specimens from the same donors. The detection methods combined three complementary techniques: pyrolysis gas chromatography-mass spectrometry to identify and quantify polymer types, attenuated total reflectance-Fourier transform infrared spectroscopy to confirm the chemical structure of detected particles, and electron microscopy with energy-dispersive spectroscopy to visually verify the morphology of the particles in tissue. The combination of three independent measurement approaches was specifically designed to address the central methodological challenge of the field: the difficulty of distinguishing genuine plastic particles in biological tissue from procedural contamination introduced during sample handling.
What the numbers actually were
The mass concentrations the team measured were higher than anyone in the field had expected. The 2016 brain samples averaged approximately 3,345 micrograms of plastic per gram of brain tissue. The 2024 samples averaged approximately 4,917 micrograms per gram. Multiplied by the average mass of an adult human brain (approximately 1,400 grams), the 2024 figure corresponds to a total brain plastic burden of approximately 7 grams — roughly the mass of a plastic spoon, in the comparison that has become the study’s most-cited shorthand. According to National Geographic’s coverage of the study, the 50 percent increase between 2016 and 2024 mirrors the steep increase in global plastic production over the same period, which Matthew Campen, the UNM toxicologist who led the project, described as “frighteningly correlated” with the rate of plastic accumulation in the broader environment.
The composition of the brain plastic was unexpected as well. The dominant polymer detected was polyethylene — the material used in single-use plastic bags, food packaging, water bottle caps, and a wide range of consumer products. Polyethylene accounted for a substantially higher proportion of the brain microplastics than it did of the microplastics in liver or kidney samples from the same donors. Other detected polymers included polypropylene, polyvinyl chloride, and styrene-butadiene rubber, with the overall mix consistent with the kinds of plastics most commonly fragmented into the environmental microplastic pool. Electron microscopy of the brain particles showed that they were predominantly nanoscale shard-like fragments, generally less than 200 nanometres long and less than 40 nanometres wide — small enough to cross biological barriers that were never evolutionarily designed to stop them.
How the plastic gets in
The blood-brain barrier is one of the more remarkable evolutionary structures in vertebrate biology. It consists of a tightly-sealed layer of endothelial cells lining the blood vessels of the brain, supplemented by specialised glial cells called astrocytes, that together prevent most molecules circulating in the bloodstream from reaching the brain’s neural tissue. The barrier has been evolving in its current form for approximately 500 million years, since early vertebrates, and its primary function is to protect the brain’s delicate neural environment from toxins, pathogens, ion fluctuations, and other potentially harmful substances that the rest of the body’s tissues regularly encounter. The barrier is impermeable to most molecules larger than about 500 daltons (a small organic molecule), and it is reinforced by active transport systems that pump out unwanted substances that do manage to cross.
According to the University of New Mexico Health Sciences Center’s institutional summary of the research, the Nihart team had expected to find some microplastic accumulation in brain tissue, on the basis of earlier animal studies and the 2024 finding of microplastics in human olfactory bulb tissue. What they had not expected was the magnitude: brain concentrations 7 to 30 times higher than concentrations in liver and kidney from the same individuals. The most plausible explanation involves the size of the particles. The detected fragments were predominantly nanoscale rather than microscale, and the smallest nanoparticles — below about 100 nanometres — appear capable of crossing the blood-brain barrier through several mechanisms, including transcytosis through endothelial cells, uptake by circulating immune cells that then migrate into the brain, and direct entry through the olfactory pathway via the nasal cavity. The barrier evolved to handle organic molecules, ions, and biological pathogens. It did not evolve to handle nanoscale fragments of synthetic polymers that did not exist on Earth before Leo Baekeland synthesised the first true plastic, Bakelite, in 1907.
The methodological challenge
The findings have not been accepted without scrutiny. According to a methodological critique published in Nature Medicine in November 2025 in response to the original Nihart paper, several independent research groups have raised concerns about the reliability of the reported concentrations. The principal objections involve the difficulty of preventing procedural contamination during sample preparation — laboratory air, plastic containers, glassware, and reagents are themselves potential sources of the very polymers being measured — and questions about whether the pyrolysis gas chromatography-mass spectrometry method, while sensitive, fully distinguishes between plastic-derived organic molecules and structurally similar organic compounds produced by tissue itself.
The Nihart team has responded to these concerns by emphasising the convergence of their three independent detection methods, the use of contamination controls, and the consistency of the findings across multiple samples and analytical approaches. The broader field is in the process of working out methodological standards for measuring microplastics in human tissue — the techniques are new, the targets are tiny, and the contamination challenges are real. What is not in dispute is that microplastics have been detected, by multiple independent research groups using multiple methods, in human blood, placenta, lungs, kidneys, livers, and now brains. The exact concentrations remain a matter of active scientific debate. The presence of the particles, in some quantity, in essentially every human tissue that has been examined for them, is now established.
What we do not yet know
The 2025 paper documented the presence of microplastics in human brains. It did not establish what those particles do once they are there. The health effects of microplastic accumulation in brain tissue, if any, are presently unknown. The Nihart team did observe that brains from individuals who had been diagnosed with dementia contained 3 to 5 times more plastic than brains from non-demented donors of similar age — a striking correlation, but one that cannot, on the current evidence, distinguish between several competing causal interpretations. The plastic could be contributing to dementia pathology. The dementia pathology could be allowing more plastic to accumulate (because of blood-brain barrier breakdown that occurs in some forms of dementia). Or some third factor — diet, environmental exposure, lifestyle — could be driving both. The cross-sectional design of the study cannot resolve which of these explanations is correct.
What the study has established, with reasonable confidence and pending replication by independent groups, is that human exposure to environmental microplastics has reached a level at which measurable quantities of those plastics are now present in the most metabolically protected tissue in the human body. The barrier that evolution spent half a billion years constructing to keep foreign matter out of the brain is, in the year 2026, demonstrably permeable to nanoparticles of a class of materials that have existed on the planet for fewer than 120 years. Whether this is medically significant, environmentally tractable, or biologically reversible are questions that the next decade of research will be working to answer. The exposure itself is no longer in doubt.
